The present investigations were undertaken in order to elucidate the effects of K
1 on the uterine motility, and the interrelationship between K
1 and ovarian hormones.
The results were as follows:
1) One, 10, 100 or 1000γ of K
1 per kg body-weight was intravenously injected to the rabbit with fistula. Immediately after the injection, the slight promotion of uterine motility is seen in case of 1, 10 or 100γy, while the inhibition after transient promotion is found in 1 mg.
But in each dose, promotion is shown at the 24th hour after the injection.
2) In case of the subcutaneous injection of 1.3 or 5 mg/kg of K
1 that is repeated once a day, the promotion of uterine motility is exhibited gradually along with the increase in number of injection time, until the inhibition is seen gradually along with its further increase.
3) The uterine motility is promoted by the use of K
1 and estrogen at the same time.
It seems that K1 has a synergistic action to estrogen.
4) In case K
1 and progesterone are used at the same time, the recovery from inhibition of uterine motility by progesterone is seen along with the increase in number of injection time.
An antagonistic action of K
1 against progesterone is suggested.
5) The sensitivity of oxytocin for uteine motility of the rabbit to which K
1 was given lowers unrelatedly with its promotion of K
1.
View full abstract